摘要
帕金森病(Parkinson’s disease,PD)是中老年人常见的神经系统变性疾病,其病因和发病机制复杂。目前认为该病是遗传与环境因素共同作用的结果。环境、遗传、年龄老化、细胞功能障碍(氧化应激、线粒体功能缺失、异常蛋白聚集、
出处
《中国综合临床》
2010年第11期1227-1229,共3页
Clinical Medicine of China
基金
上海市科委纳米专项基金(0952nm03700)
上海市基础研究重点项目(09JC1411000)
参考文献11
-
1Parkinson Study Group CALM Cohort Investigators. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease [ J]. Arch Neuro1,2009,66 (5) :563-570.
-
2Palhagen S, Heinonen E, Hagglund J, et al. Selegiline slows the progression of the symptoms of Parkinson disease [ J]. Neurology, 2006,66 ( 8 ) : 1200-1206.
-
3Olanow CW, Rascol O, Hauser R, et al. A double-blind, delayed- start trial of rasagiline in Parkinson's disease [J]. N Engl J Med, 2009,361 ( 13 ) : 1268-1278.
-
4Storch A, Jost WH, Vieregge P, et al. Randomized, double-blind, placebo-controlled trim on symptomatic effects of coenzyme Q ( 10 ) in Parkinson disease [ J]. Arch Neurol,2007,64(7) :938-944.
-
5Olanow CW, Schapira AH, LeWitt PA, et al. TCI-D46 as a neuroprotective drug in Parkinson' s disease: a double-blind, randomised, controlled thai [ J ]. Lancet Neuro1,2006,5 ( 12 ) : 1013- 1020.
-
6Parkinson Study Group PRECEPT Investigators. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease [ J ]. Neurology,2007,69 ( 15 ) : 1480-1490.
-
7NINDS NET-PD Investigators. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease [ J]. Neurology,2006,66(5 ) :664-671.
-
8Slevin JT, Gerhardt GA, Smith CD, et al. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor [ J ]. J Neurosurg,2005,102 (2) :216-222.
-
9Lang AE, Gill S, Patel NK, et al. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease [ J]. Ann Neurol,2006,59 (3) :459-466.
-
10Marks WJ Jr, Ostrem JL, Verhagen L, et al. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin ) to patients with idiopathic Parkinson's disease:an open-label, phase I trial [J]. Lancet Neurol,2008,7 (5) :400-408.
同被引文献26
-
1Hauser RA,Zesiewicz TA.Advances in the pharmacologic management of early Parkinson's disease.Neurolgist,2007,13(3):126.
-
2Muriel MP,Bemzrd V,Levey AI,et al.Levodopa induences a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.Ann Neurol,1999,46(1):103-111.
-
3Schapira AH.Science,medicine and the future:Parkinson's disease.BMJ,1999,318(7179):311-314.
-
4Dryja TP,O'Neil-Dryja M,Pawelek JM,et al.Demonstration of tyrosinase in the adult bovine uveal tract and retinal pigment epithelium[J].Invest Ophthalmol Vis Sci,1978,17(6):511-514.
-
5Smith SB,Zhou BK,Orlow SJ.Expression of tyrosinase and the tyrosinase related proteins in the Mitfvit(vitiligo)mouse eye:implications for the function of the microphthalmia transcription factor[J].Exp Eye Res,1998,66(4):403-410.
-
6Castillo BV Jr,Little CW,del Cerro C,et al.An improved method of isolating fetal human retinal pigment epithelium[J].Curr Eye Res,1995,14(8):677-683.
-
7Connor B,Kozlowski DA,Unnerstall JR,et al.Glial cell line-derived neurotrophic factor(GDNF)gene delivery protects dopaminergic terminals from degeneration[J].Exp Neurol,2001,169(1):83-95.
-
8Sun M,Kong L,Wang X,et al.Comparison of the capability of GDNF,BDNF,or both,to protect nigrostriatal neurons in a rat model of Parkinson's disease[J].Brain Res,2005,1052(2):119-129.
-
9Subramanian T.Cell transplantation for the treatment of Parkinson's disease[J].Semin Neurol,2001,21(1):103-115.
-
10吴钢,蔡端,邬剑华,马保金,张延龄,李保国,龚佳蕾,肖强.大鼠胰岛与生长因子共微囊提高囊内胰岛存活率[J].复旦学报(医学版),2008,35(1):107-110. 被引量:1
引证文献3
-
1杨丹晓,谢阗,刘少玲.普拉克索联合左旋多巴/苄丝肼治疗晚期帕金森病的疗效观察[J].中国基层医药,2011,18(9):1186-1187. 被引量:9
-
2高冬晓,赵亚群,刘江,王永.改善微囊化人视网膜色素上皮细胞生长状态的研究[J].中国综合临床,2011,27(5):488-490.
-
3李献军,刘永,孟丽,张军,王学明,宋哲.血尿酸水平与帕金森病病情分级的相关性研究[J].中国综合临床,2013,29(3):278-280. 被引量:5
二级引证文献14
-
1蔡学兵.一贯煎合芍药甘草汤加虫类药物联合多巴丝肼治疗帕金森综合征[J].中国实用神经疾病杂志,2012,15(20):80-81. 被引量:5
-
2陈斌.盐酸普拉克索联合美多芭治疗帕金森病56例临床观察[J].河北联合大学学报(医学版),2014,16(2):224-225. 被引量:16
-
3邱菊,杜静,饶静,高宗良.帕金森病患者血清尿酸水平与临床症状的相关性研究[J].安徽医学,2014,35(8):1061-1064. 被引量:3
-
4赵国梁,于虎,张鹰,张中林.老年髋部骨折合并帕金森病的围手术期处理策略[J].浙江创伤外科,2014,19(4):604-605.
-
5余健敏,潘小平.血尿酸水平与帕金森病患病率及其认知功能改变、病情分级相关性探讨[J].现代医院,2014,14(10):16-18. 被引量:1
-
6余健敏,潘小平.帕金森病患者认知功能与血尿酸水平的关系[J].广东医学,2015,36(5):715-716. 被引量:5
-
7白璇.盐酸普拉克索片治疗帕金森病患者的临床疗效[J].中国药物经济学,2016,11(1):23-25. 被引量:11
-
8李冰.普拉克索治疗帕金森病的临床效果评价[J].中国处方药,2016,14(12):100-101. 被引量:1
-
9范建华,王培娟,吴郁琼.老年帕金森病患者发生认知障碍的影响因素研究[J].临床心身疾病杂志,2016,22(6):94-96. 被引量:5
-
10纵锋,程健.复方左旋多巴联合普拉克索治疗帕金森病临床观察[J].中国实用医药,2017,12(20):122-123. 被引量:3
-
1范丽,杨新玲.新疆地区帕金森病患者发病因素[J].中国老年学杂志,2015,35(6):1685-1687. 被引量:2
-
2熊婧,张兆辉.农药与帕金森病的相关性研究进展[J].中国神经免疫学和神经病学杂志,2016,23(6):438-442. 被引量:1
-
3伍雪英,龚玉来,何进宇.帕金森病的研究进展[J].现代临床医学,2007,33(z2):174-177. 被引量:3
-
4刘丽霞,周盛年,张晓,朴莲春,张正达.年龄老化对缺血性脑卒中发生发展和恢复的影响[J].中国老年学杂志,2012,32(2):417-420. 被引量:27
-
5佘正明.手抖是帕金森病主要症状 但不是唯一[J].现代养生,2014,0(2):14-15.
-
6刘崇,李冬晓,郭艳苏.少突胶质细胞功能障碍与肌萎缩侧索硬化症[J].脑与神经疾病杂志,2016,24(5):327-330. 被引量:1
-
7贾建平,王芬,袁泉,秦伟,唐毅,左秀美,韩阅.老年性痴呆早期的基因变异研究进展[J].生物化学与生物物理进展,2012,39(8):698-702. 被引量:14
-
8吴凌云.多发性硬化的MRI表现及诊断价值的评价[J].全科医学临床与教育,2015,13(3):324-325.
-
9张佳佳,高君.冠心病危险因素[J].中国社区医师,2004,20(18):9-9. 被引量:1
-
10姜童子,陈鑫.帕金森病患者认知功能与血尿酸等生化指标相关性分析[J].中国现代医药杂志,2016,18(6):66-68.